Esprit BTK Shows Fewer Repeat Interventions Than Balloon Angioplasty

Patients with peripheral artery disease below the knee who were treated with Abbott’s Esprit BTK system need fewer repeat procedures after two years than a control group that received balloon angioplasty, the company announced Monday.

Esprit BTK became the first resorbable stent approved by the US Food and Drug Administration to...